Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04425629 |
|---|---|
| Brief Title: | Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19 |
| First Submitted : | June 8, 2020 |
| First Submitted that Met QC Criteria : | June 8, 2020 |
| First Posted : | June 11, 2020 |
| Last Update Submitted that Met QC Criteria : | March 31, 2021 |
| Last Update Posted : | April 5, 2021 |